Detalhe da pesquisa
1.
The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates.
Eur J Nucl Med Mol Imaging
; 44(5): 788-800, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28083690
2.
Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.
Eur J Nucl Med Mol Imaging
; 44(5): 765-775, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27900519
3.
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.
Eur J Nucl Med Mol Imaging
; 44(6): 941-949, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28138747
4.
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
Eur J Nucl Med Mol Imaging
; 44(10): 1647-1655, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28589253
5.
Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
Eur J Nucl Med Mol Imaging
; 43(9): 1585-92, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26922350
6.
Accuracy and feasibility of three different methods for software-based image fusion in whole-body PET and CT.
Q J Nucl Med Mol Imaging
; 60(2): 172-81, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27064496
7.
Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism.
Eur J Nucl Med Mol Imaging
; 42(13): 1995-2001, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26173620
8.
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Eur J Nucl Med Mol Imaging
; 42(8): 1284-94, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975367
9.
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Eur J Nucl Med Mol Imaging
; 38(5): 865-73, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21279352
10.
68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy.
J Nucl Med
; 50(9): 1427-34, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19690033
11.
Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
J Nucl Med
; 50(8): 1214-21, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19617343
12.
Multimodal evaluation of renal perfusional changes due to extracorporeal shock wave lithotripsy.
BJU Int
; 101(6): 731-5, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17941931
13.
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.
J Nucl Med
; 48(4): 508-18, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17401086
14.
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification.
Eur J Nucl Med Mol Imaging
; 39(3): 543, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237841
15.
Detection of Sarcomatoid Lung Metastasis With 68GA-PSMA PET/CT in a Patient With Prostate Cancer.
Clin Nucl Med
; 41(5): 421-2, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26859209
16.
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
PLoS One
; 10(5): e0125364, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26020783
17.
An individual dosimetric approach to 153Sm-EDTMP therapy for pain palliation in bone metastases in correlation with clinical results.
Nucl Med Commun
; 25(4): 367-73, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15097811
18.
First experience using peptide receptor radionuclide therapy in a patient with urothelial carcinoma.
Clin Nucl Med
; 38(10): e404-6, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23579972
19.
Fluorine-18-fluorodeoxyglucose positron emission tomography as a novel noninvasive diagnostic tool for gastrointestinal graft-versus-host disease.
Transplantation
; 84(3): 440-1, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17700174
20.
First experience with proteasome inhibitor treatment of radioiodine nonavid thyroid cancer using bortezomib.
Clin Nucl Med
; 37(6): 539-44, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22614183